Vasorelaxant effect of sinensetin via the NO/sGC/cGMP pathway and potassium and calcium channels

• Published in: Hypertension research 2018-10, Vol.41 (10), p.787-797
• Main Authors: Yam, Mun Fei, Tan, Chu Shan, Shibao, Ruan
• Format: Article
• Language: English
• Subjects: Endothelium; Nitric oxide; Potassium
• ISSN: 0916-9636; 1348-4214
• DOI: 10.1038/s41440-018-0083-8

Orthosiphon stamineus Benth. (Lambiaceae) is an important traditional plant for the treatment of hypertension. Previous studies have demonstrated that the sinensetin content in O. stamineus is correlated with its vasorelaxant activity. However, there is still very little information regarding the vasorelaxant effect of sinensetin due to a lack of scientific studies. Therefore, the present study was designed to investigate the underlying mechanism of action of sinensetin in vasorelaxation using an in vitro precontraction aortic ring assay. The changes in the tension of the aortic ring preparations were recorded using a force-displacement transducer and the PowerLab system. The mechanisms of the vasorelaxant effect of sinensetin were determined in the presence of antagonists. Sinensetin caused relaxation of the aortic ring precontracted with PE in the presence and absence of the endothelium and with potassium chloride in endothelium-intact aortic rings. In the presence of Nω-nitro-L-arginine methyl ester (nitric oxide synthase inhibitor), methylene blue (cyclic guanosine monophosphate lowering agent), ODQ (selective soluble guanylate cyclase inhibitor), indomethacin (a nonselective cyclooxygenase inhibitor), tetraethylammonium (nonselective calcium activator K channel blocker), 4-aminopyridine (voltage-dependent K channel blocker), barium chloride (inwardly rectifying K channel blocker), glibenclamide (nonspecific ATP-sensitive K channel blocker), atropine (muscarinic receptor blocker), or propranolol (β-adrenergic receptor blocker), the relaxation stimulated by sinensetin was significantly reduced. Sinensetin was also active in reducing Ca release from the sarcoplasmic reticulum (via IP R) and in blocking calcium channels (VOCC). The present study demonstrates the vasorelaxant effect of sinensetin, which involves the NO/sGC/cGMP and indomethacin pathways, calcium and potassium channels, and muscarinic and beta-adrenergic receptors.